Behçet disease – Case presentation

Behcet's disease is a rare and poorly understood condition with multiple systemic manifestations. The disease causes inflammation in blood vessels throughout the body which leads to numerous symptoms that may appear and disappear unpredictable. Case presentation A 33 year old woman was admi...

Full description

Bibliographic Details
Main Authors: Lucian M. Ciobîcă, Sârbu Iolanda, Silviu M. Stanciu, Ancuţa Coca
Format: Article
Language:English
Published: Carol Davila University of Medicine and Pharmacy Publishing House 2016-12-01
Series:Romanian Journal of Military Medicine
Online Access:http://revistamedicinamilitara.ro/wp-content/uploads/2017/01/RJMM-vol-CXIX-nr-3-din-2016.45-48.pdf
id doaj-ac35cc12732a4016855b73f3fbb2841b
record_format Article
spelling doaj-ac35cc12732a4016855b73f3fbb2841b2020-11-25T01:33:23ZengCarol Davila University of Medicine and Pharmacy Publishing HouseRomanian Journal of Military Medicine1222-51262501-23122016-12-01CXIX34346Behçet disease – Case presentationLucian M. CiobîcăSârbu Iolanda Silviu M. StanciuAncuţa CocaBehcet's disease is a rare and poorly understood condition with multiple systemic manifestations. The disease causes inflammation in blood vessels throughout the body which leads to numerous symptoms that may appear and disappear unpredictable. Case presentation A 33 year old woman was admitted (interned) to our clinic. Her family medical history reveals – multiple strokes (father) and autoimmune thyroiditis (sister). The onset of her symptomatology was in 2013 and it consisted of fever (39-40 Celsius degrees) sicca syndrome and persistent headaches, recurrent oral and genital ulcerations. An important event is essential to be mentioned -the patients has suffered an episode of upper gastrointestinal bleeding (hemoglobin has dropped to 2.5g/dl which has led to cardiac arrestresuscitated). The lab tests showed: C3 hypocomplementemia, Anti-centromere antibodies (-), anti-b2gp1 antibody (+), lupus anticoagulant (+), U1RNP(-). We started to administrate cyclophosphamide to the patient, thus his condition has improved after the 2nd dose. At the 12-month evaluation we were able to see a significant clinical and biological improvement. Conclusions In order to be able to talk about “evidence based medicine” for the management of Bechet’s disease, a large number of clinical trials is required to provide to the attending physicians the necessary data for diagnosis and treatment. http://revistamedicinamilitara.ro/wp-content/uploads/2017/01/RJMM-vol-CXIX-nr-3-din-2016.45-48.pdf
collection DOAJ
language English
format Article
sources DOAJ
author Lucian M. Ciobîcă
Sârbu Iolanda
Silviu M. Stanciu
Ancuţa Coca
spellingShingle Lucian M. Ciobîcă
Sârbu Iolanda
Silviu M. Stanciu
Ancuţa Coca
Behçet disease – Case presentation
Romanian Journal of Military Medicine
author_facet Lucian M. Ciobîcă
Sârbu Iolanda
Silviu M. Stanciu
Ancuţa Coca
author_sort Lucian M. Ciobîcă
title Behçet disease – Case presentation
title_short Behçet disease – Case presentation
title_full Behçet disease – Case presentation
title_fullStr Behçet disease – Case presentation
title_full_unstemmed Behçet disease – Case presentation
title_sort behçet disease – case presentation
publisher Carol Davila University of Medicine and Pharmacy Publishing House
series Romanian Journal of Military Medicine
issn 1222-5126
2501-2312
publishDate 2016-12-01
description Behcet's disease is a rare and poorly understood condition with multiple systemic manifestations. The disease causes inflammation in blood vessels throughout the body which leads to numerous symptoms that may appear and disappear unpredictable. Case presentation A 33 year old woman was admitted (interned) to our clinic. Her family medical history reveals – multiple strokes (father) and autoimmune thyroiditis (sister). The onset of her symptomatology was in 2013 and it consisted of fever (39-40 Celsius degrees) sicca syndrome and persistent headaches, recurrent oral and genital ulcerations. An important event is essential to be mentioned -the patients has suffered an episode of upper gastrointestinal bleeding (hemoglobin has dropped to 2.5g/dl which has led to cardiac arrestresuscitated). The lab tests showed: C3 hypocomplementemia, Anti-centromere antibodies (-), anti-b2gp1 antibody (+), lupus anticoagulant (+), U1RNP(-). We started to administrate cyclophosphamide to the patient, thus his condition has improved after the 2nd dose. At the 12-month evaluation we were able to see a significant clinical and biological improvement. Conclusions In order to be able to talk about “evidence based medicine” for the management of Bechet’s disease, a large number of clinical trials is required to provide to the attending physicians the necessary data for diagnosis and treatment.
url http://revistamedicinamilitara.ro/wp-content/uploads/2017/01/RJMM-vol-CXIX-nr-3-din-2016.45-48.pdf
work_keys_str_mv AT lucianmciobica behcetdiseasecasepresentation
AT sarbuiolanda behcetdiseasecasepresentation
AT silviumstanciu behcetdiseasecasepresentation
AT ancutacoca behcetdiseasecasepresentation
_version_ 1725077602634301440